Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.
Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This document describes evidence-based clinical guidelines for the management of thyrotoxic...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Endocrinology Research Centre
2017-12-01
|
Series: | Клиническая и экспериментальная тиреоидология |
Subjects: | |
Online Access: | https://cet-endojournals.ru/ket/article/viewFile/9474/7083 |
id |
doaj-68b5fbfc5cf84dcb914418a12a98f410 |
---|---|
record_format |
Article |
spelling |
doaj-68b5fbfc5cf84dcb914418a12a98f4102021-06-02T19:40:46ZrusEndocrinology Research CentreКлиническая и экспериментальная тиреоидология1995-54722310-37872017-12-01133455610.14341/ket2017345-568384Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.Valentin V. Fadeyev0I.M. Sechenov First Moscow State Medical UniversityThyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This document describes evidence-based clinical guidelines for the management of thyrotoxicosis that would be useful to generalist and subspecialty physicians and others providing care for patients with this condition. The American Thyroid Association (ATA) previously cosponsored guidelines for the management of thyrotoxicosis that were published in 2011. Considerable new literature has been published since then, and the ATA felt updated evidence-based guidelines were needed. The association assembled a task force of expert clinicians who authored this report. They examined relevant literature using a systematic PubMed search supplemented with additional published materials. An evidence-based medicine approach that incorporated the knowledge and experience of the panel was used to update the 2011 text and recommendations. The strength of the recommendations and the quality of evidence supporting them were rated according to the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation Group. Clinical topics addressed include the initial evaluation and management of thyrotoxicosis; management of Graves hyperthyroidism using radioactive iodine, antithyroid drugs, or surgery; management of toxic multinodular goiter or toxic adenoma using radioactive iodine or surgery; Graves disease in children, adolescents, or pregnant patients; subclinical hyperthyroidism; hyperthyroidism in patients with Graves orbitopathy; and management of other miscellaneous causes of thyrotoxicosis. New paradigms since publication of the 2011 guidelines are presented for the evaluation of the etiology of thyrotoxicosis, the management of Graves hyperthyroidism with antithyroid drugs, the management of pregnant hyperthyroid patients, and the preparation of patients for thyroid surgery. The sections on less common causes of thyrotoxicosis have been expanded. One hundred twenty-four evidence-based recommendations were developed to aid in the care of patients with thyrotoxicosis and to share what the task force believes is current, rational, and optimal medical practice.https://cet-endojournals.ru/ket/article/viewFile/9474/7083thyrotoxicosishyperthyroidismgraves’ diseaseradioactive iodineantithyroid drugstoxic multinodular goitertoxic adenomasubclinical hyperthyroidism |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
Valentin V. Fadeyev |
spellingShingle |
Valentin V. Fadeyev Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Клиническая и экспериментальная тиреоидология thyrotoxicosis hyperthyroidism graves’ disease radioactive iodine antithyroid drugs toxic multinodular goiter toxic adenoma subclinical hyperthyroidism |
author_facet |
Valentin V. Fadeyev |
author_sort |
Valentin V. Fadeyev |
title |
Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. |
title_short |
Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. |
title_full |
Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. |
title_fullStr |
Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. |
title_full_unstemmed |
Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. |
title_sort |
review of american thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. |
publisher |
Endocrinology Research Centre |
series |
Клиническая и экспериментальная тиреоидология |
issn |
1995-5472 2310-3787 |
publishDate |
2017-12-01 |
description |
Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This document describes evidence-based clinical guidelines for the management of thyrotoxicosis that would be useful to generalist and subspecialty physicians and others providing care for patients with this condition. The American Thyroid Association (ATA) previously cosponsored guidelines for the management of thyrotoxicosis that were published in 2011. Considerable new literature has been published since then, and the ATA felt updated evidence-based guidelines were needed. The association assembled a task force of expert clinicians who authored this report. They examined relevant literature using a systematic PubMed search supplemented with additional published materials. An evidence-based medicine approach that incorporated the knowledge and experience of the panel was used to update the 2011 text and recommendations. The strength of the recommendations and the quality of evidence supporting them were rated according to the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation Group. Clinical topics addressed include the initial evaluation and management of thyrotoxicosis; management of Graves hyperthyroidism using radioactive iodine, antithyroid drugs, or surgery; management of toxic multinodular goiter or toxic adenoma using radioactive iodine or surgery; Graves disease in children, adolescents, or pregnant patients; subclinical hyperthyroidism; hyperthyroidism in patients with Graves orbitopathy; and management of other miscellaneous causes of thyrotoxicosis. New paradigms since publication of the 2011 guidelines are presented for the evaluation of the etiology of thyrotoxicosis, the management of Graves hyperthyroidism with antithyroid drugs, the management of pregnant hyperthyroid patients, and the preparation of patients for thyroid surgery. The sections on less common causes of thyrotoxicosis have been expanded. One hundred twenty-four evidence-based recommendations were developed to aid in the care of patients with thyrotoxicosis and to share what the task force believes is current, rational, and optimal medical practice. |
topic |
thyrotoxicosis hyperthyroidism graves’ disease radioactive iodine antithyroid drugs toxic multinodular goiter toxic adenoma subclinical hyperthyroidism |
url |
https://cet-endojournals.ru/ket/article/viewFile/9474/7083 |
work_keys_str_mv |
AT valentinvfadeyev reviewofamericanthyroidassociationguidelinesfordiagnosisandmanagementofhyperthyroidismandothercausesofthyrotoxicosis |
_version_ |
1721401492575879168 |